Zenith Provides Update Regarding Extension of its Filing Calendar
Zenith Capital Corp. (“Zenith” or the “Company”) announces that, further to its August 26, 2020. it continues to rely on blanket exemptions issued by provincial securities commissions due to the COVID-19 outbreak that permit the Company to extend the filing deadline of certain continuous disclosure documents for a period of up to 45 days. The … Continue reading Zenith Provides Update Regarding Extension of its Filing Calendar Continue Reading


Purpose Investments Inc. is pleased to announce the following distributions for the month of September 2020. The ex-distribution date for all ETFs is September 25, 2020, with the exception of Purpose High Interest Savings ETF and Purpose US Cash ETF, which have an ex-distribution date of September 29, 2020. The ex-distribution date for all closed-end …
First Quantum Minerals Ltd. announced that it has successfully completed the pricing of its offering (the “Offering”) of $1,500 million aggregate principal amount of 6.875% Senior Notes due 2027 (the “Notes”). The original offering amount of the Notes of $1,000 million has been increased to $1,500 million. The issue price of the Notes is 100.000%. Interest …
Gold Bull Resources Corp. is pleased to announce it has executed a Letter of Intent (“LOI”) to acquire 100% of the Coyote Mine project (“Coyote” or the “Project”) from private company Desert Mountain Gold LLC. Coyote is located in Juab County, Western Utah, USA and is considered prospective for gold and silver mineralisation. The Project …
Trillium Therapeutics Inc. , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the closing of its previously announced underwritten public offering of common shares of the Company at a public offering price of US$13.00 per common share (the “Offering”). 11,500,000 common shares were sold in the Offering, including …
Lift & Co. Corp. announced that it has made a voluntary assignment for the benefit of its creditors under section 49 of the Bankruptcy and Insolvency Act (Canada) and that all of its directors and officers have resigned. This follows the failure to reach an agreement with the holders (the “Debentureholders”) of the Corporation’s secured convertible debentures …
89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the pricing of an upsized underwritten public offering of 3,300,000 shares of its common stock at a public offering price of $28.00 per share. 3,025,000 shares are being offered by 89bio, …
Reference is made to the stock exchange notices published by Thin Film Electronics ASA (the “Company”) on 1 and 16 September 2020 regarding the Subsequent Offering. The subscription period under the Subsequent Offering expired on 15 September 2020 at 16:30 CET, and the Subsequent Offering was more than nine times oversubscribed, including subscriptions from eligible …